Conclusion: Doxorubicin phospholipid nanoparticle is able to become a new drugtargeting carrier system.
结论:肝癌特异性多柔比星免疫磷脂纳米粒,有可能成为一种新的药物靶向载体系统。
2
OBJECTIVE: to introduce the research and application of liver targeting chitosan drug nano-carrier system.
目的:阐述肝靶向性壳聚糖基纳米载药体系的研究和应用。
3
In addition, due to the specific actions of CMM on intestinal diseases, oral colon targetingdrug delivery system is considered substantials for TODDSs of CMM.